Cardiovascular disease - DiabetesontheNet

Stroke mortality risk increased by hyperglycaemia

Low-dose aspirin for cardiovascular protection in diabetes: Is it still justified?

Diabetes outcomes in people with low and preserved ejection fraction heart failure

Predicting CVD risk in England and Wales: Validation of QRISK

Blockade of the renin–angiotensin–aldosterone system reduces risk of end-stage renal disease

Is insulin therapy of benefit with respect to cardiovascular disease outcomes in people with type 2 diabetes?

Metabolic syndrome: A risk factor for myocardial infarction and diabetes in young Britons

Noticeboard: Vol 12 No 8

How low should you go? New data on intensive glucose lowering in type 2 diabetes

Does intensive glycaemic control provide cardiovascular benefit?

Importance of enhanced care for patients of South Asian origin with type 2 diabetes

High risk of cardiovascular disease in patients with diabetes who require glucose lowering therapy

One in seven patients with diabetes has undiagnosed peripheral arterial disease

Cardiac CT: A review of its role in stratifying risk and early detection of silent CAD

Noticeboard: Vol 12 No 7

Diabetes and CVD in South Asians: A review

Deprivation, diabetes and cardiovascular risk factors

Intensive multifactorial care in high-risk people with type 2 diabetes leads to reduced death and CV morbidity